Long non-coding RNA PVT1 activates hepatic stellate cells through competitively binding microRNA-152

Oncotarget

Volumn 7, Issue 39, 2016, Pages 62886-62897

  Zheng, Jianjian ^a,b   Yu, Fujun ^b   Dong, Peihong ^b   Wu, Limei ^a   Zhang, Yuan ^a   Hu, Yanwei ^a   Zheng, Lei ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

DNA methylation; MicroRNA 152; Patched1 (PTCH1); Pathology Section; Plasmacytoma variant translocation 1 (PVT1)

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CARBON TETRACHLORIDE; COLLAGEN; COLLAGEN TYPE 1; DESMIN; LONG UNTRANSLATED RNA; MICRORNA; MICRORNA 152; PLASMACYTOMA VARIANT TRANSLOCATION; PROTEIN PATCHED 1; SHORT HAIRPIN RNA; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; ACTIN; HYDROXYPROLINE; MIRN152 MICRORNA, HUMAN; PTCH PROTEIN, HUMAN; PVT1 LONG-NON-CODING RNA, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; COMPETITIVE BINDING ASSAY; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENE SILENCING; IN VITRO STUDY; IN VIVO STUDY; LIVER FIBROSIS; LUCIFERASE ASSAY; MALE; MOUSE; NONHUMAN; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN RNA BINDING; RNA BINDING; SIGNAL TRANSDUCTION; STELLATE CELL; UPREGULATION; ANIMAL; C57BL MOUSE; CELL MOTION; CHEMISTRY; CPG ISLAND; FIBROSIS; GENETIC EPIGENESIS; GENETICS; HEPATIC STELLATE CELL; HUMAN; LIVER; METABOLISM; PATHOLOGY; RNA INTERFERENCE;

ACTINS; ANIMALS; CELL MOVEMENT; COLLAGEN; COLLAGEN TYPE I; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROSIS; GENE SILENCING; HEPATIC STELLATE CELLS; HUMANS; HYDROXYPROLINE; LIVER; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; PATCHED-1 RECEPTOR; RNA INTERFERENCE; RNA, LONG NONCODING; UP-REGULATION;

EID: 84993154642     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.11709     Document Type: Article

References (37)

1. Zhao Q, Qin CY, Zhao ZH, Fan YC and Wang K. Epigenetic modifications in hepatic stellate cells contribute to liver fibrosis. Tohoku J Exp Med. 2013; 229:35-43.
2. Wang J, Chu ES, Chen HY, Man K, Go MY, Huang XR, Lan HY, Sung JJ and Yu J. microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway. Oncotarget. 2015; 6:7325-7338. doi: 10.18632/oncotarget.2621.
3. Popov Y and Schuppan D. Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Hepatology. 2009; 50:1294-1306.
4. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008; 88:125-172.
5. Chen Y, Zheng S, Qi D, Guo J, Zhang S and Weng Z. Inhibition of Notch signaling by a gamma-secretase inhibitor attenuates hepatic fibrosis in rats. PLoS One. 2012; 7:e46512.
6. Choi SS, Syn WK, Karaca GF, Omenetti A, Moylan CA, Witek RP, Agboola KM, Jung Y, Michelotti GA and Diehl AM. Leptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway. J Biol Chem. 2010; 285:36551-36560.
7. Choi SS, Omenetti A, Witek RP, Moylan CA, Syn WK, Jung Y, Yang L, Sudan DL, Sicklick JK, Michelotti GA, Rojkind M and Diehl AM. Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis. Am J Physiol Gastrointest Liver Physiol. 2009; 297:G1093-1106.
8. Yu F, Lu Z, Chen B, Wu X, Dong P and Zheng J. Salvianolic acid B-induced microRNA-152 inhibits liver fibrosis by attenuating DNMT1-mediated Patched1 methylation. J Cell Mol Med. 2015; 19:2617-2632.
9. Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ, Tao QF, Liu F, Pan W, Wang TT, Zhou CC, Wang SB, Wang YZ, Yang Y, Yang N, Zhou WP, Yang GS, et al. A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell. 2014; 25:666-681.
10. Fatica A and Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2014; 15:7-21.
11. He Y, Wu YT, Huang C, Meng XM, Ma TT, Wu BM, Xu FY, Zhang L, Lv XW and Li J. Inhibitory effects of long noncoding RNA MEG3 on hepatic stellate cells activation and liver fibrogenesis. Biochim Biophys Acta. 2014; 1842:2204-2215.
12. Yu F, Zheng J, Mao Y, Dong P, Li G, Lu Z, Guo C, Liu Z and Fan X. Long non-coding RNA APTR promotes the activation of hepatic stellate cells and the progression of liver fibrosis. Biochem Biophys Res Commun. 2015; 463:679-685.
13. Wang F, Yuan JH, Wang SB, Yang F, Yuan SX, Ye C, Yang N, Zhou WP, Li WL, Li W and Sun SH. Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2. Hepatology. 2014; 60:1278-1290.
14. Liu E, Liu Z and Zhou Y. Carboplatin-docetaxel-induced activity against ovarian cancer is dependent on up-regulated lncRNA PVT1. Int J Clin Exp Pathol. 2015; 8:3803-3810.
15. Yang YR, Zang SZ, Zhong CL, Li YX, Zhao SS and Feng XJ. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer. Int J Clin Exp Pathol. 2014; 7:6929-6935.
16. Kong R, Zhang EB, Yin DD, You LH, Xu TP, Chen WM, Xia R, Wan L, Sun M, Wang ZX, De W and Zhang ZH. Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16. Mol Cancer. 2015; 14:82.
17. Ding C, Yang Z, Lv Z, Du C, Xiao H, Peng C, Cheng S, Xie H, Zhou L, Wu J and Zheng S. Long non-coding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patients. Oncol Lett. 2015; 9:955-963.
18. Alvarez ML, Khosroheidari M, Eddy E and Kiefer J. Role of microRNA 1207-5P and its host gene, the long noncoding RNA Pvt1, as mediators of extracellular matrix accumulation in the kidney: implications for diabetic nephropathy. PLoS One. 2013; 8:e77468.
19. Sekiya Y, Ogawa T, Yoshizato K, Ikeda K and Kawada N. Suppression of hepatic stellate cell activation by microRNA-29b. Biochem Biophys Res Commun. 2011; 412:74-79.
20. Ribon V, Johnson JH, Camp HS and Saltiel AR. Thiazolidinediones and insulin resistance: peroxisome proliferatoractivated receptor gamma activation stimulates expression of the CAP gene. Proc Natl Acad Sci U S A. 1998; 95:14751-14756.
21. Yang JJ, Tao H, Huang C, Shi KH, Ma TT, Bian EB, Zhang L, Liu LP, Hu W, Lv XW and Li J. DNA methylation and MeCP2 regulation of PTCH1 expression during rats hepatic fibrosis. Cell Signal. 2013; 25:1202-1211.
22. Shi X, Sun M, Liu H, Yao Y and Song Y. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013; 339:159-166.
23. Sarver AL and Subramanian S. Competing endogenous RNA database. Bioinformation. 2012; 8:731-733.
24. Xing CY, Hu XQ, Xie FY, Yu ZJ, Li HY, Bin Z, Wu JB, Tang LY and Gao SM. Long non-coding RNA HOTAIR modulates c-KIT expression through sponging miR-193a in acute myeloid leukemia. FEBS Lett. 2015; 589:1981-1987.
25. Liang WC, Fu WM, Wong CW, Wang Y, Wang WM, Hu GX, Zhang L, Xiao LJ, Wan DC, Zhang JF and Waye MM. The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. Oncotarget. 2015; 6:22513-22525. doi: 10.18632/oncotarget.4154.
26. Yu F, Zheng J, Mao Y, Dong P, Lu Z, Li G, Guo C, Liu Z and Fan X. Long Non-coding RNA Growth Arrest-specific Transcript 5 (GAS5) Inhibits Liver Fibrogenesis through a Mechanism of Competing Endogenous RNA. J Biol Chem. 2015; 290:28286-28298.
27. Wang F, Ying HQ, He BS, Pan YQ, Deng QW, Sun HL, Chen J, Liu X and Wang SK. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget. 2015; 6:7899-7917. doi: 10.18632/oncotarget.3219.
28. Riquelme E, Suraokar MB, Rodriguez J, Mino B, Lin HY, Rice DC, Tsao A and Wistuba, II. Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma. J Thorac Oncol. 2014; 9:998-1007.
29. Paci P, Colombo T and Farina L. Computational analysis identifies a sponge interaction network between long noncoding RNAs and messenger RNAs in human breast cancer. BMC Syst Biol. 2014; 8:83.
30. Benetatos L, Dasoula A, Hatzimichael E, Georgiou I, Syrrou M and Bourantas KL. Promoter hypermethylation of the MEG3 (DLK1/MEG3) imprinted gene in multiple myeloma. Clin Lymphoma Myeloma. 2008; 8:171-175.
31. El Taghdouini A, Sorensen AL, Reiner AH, Coll M, Verhulst S, Mannaerts I, Oie CI, Smedsrod B, Najimi M, Sokal E, Luttun A, Sancho-Bru P, Collas P and van Grunsven LA. Genome-wide analysis of DNA methylation and gene expression patterns in purified, uncultured human liver cells and activated hepatic stellate cells. Oncotarget. 2015; 6:26729-26745. doi: 10.18632/oncotarget.4925.
32. Goll MG and Bestor TH. Eukaryotic cytosine methyltransferases. Annu Rev Biochem. 2005; 74:481-514.
33. Wu X, Zhao B, Cheng Y, Yang Y, Huang C, Meng X, Wu B, Zhang L, Lv X and Li J. Melittin induces PTCH1 expression by down-regulating MeCP2 in human hepatocellular carcinoma SMMC-7721 cells. Toxicol Appl Pharmacol. 2015; 288:74-83.
34. Chang W, Yang M, Song L, Shen K, Wang H, Gao X, Li M, Niu W and Qin X. Isolation and culture of hepatic stellate cells from mouse liver. Acta Biochim Biophys Sin (Shanghai). 2014; 46:291-298.
35. Schmittgen TD and Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008; 3:1101-1108.
36. Ji W, Yang L, Yu L, Yuan J, Hu D, Zhang W, Yang J, Pang Y, Li W, Lu J, Fu J, Chen J, Lin Z, Chen W and Zhuang Z. Epigenetic silencing of O6-methylguanine DNA methyltransferase gene in NiS-transformed cells. Carcinogenesis. 2008; 29:1267-1275.
37. Wang K, Liu F, Zhou LY, Long B, Yuan SM, Wang Y, Liu CY, Sun T, Zhang XJ and Li PF. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489. Circ Res. 2014; 114:1377-1388.